Health · World
US FDA Approves New Breast Cancer Drug Combination
The U.S. Food and Drug Administration (FDA) has approved a new combination drug therapy for breast cancer. The treatment, known as Inlyta-Verzenio, is intended for patients whose tumors are estrogen receptor-positive. The approval was granted by the US FDA.
How outlets across the spectrum covered it
L 0 C 3 R 0
- Centre (3): Reuters, The Economic Times, The Hindu BusinessLine